Adaptive Biotechnologies Stock

Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.

Get your daily dose of news with exclusive content, articles, and more at The Market Globalist, a free online newspaper launched in May 2010. They’re young, but ambitious, aiming to deliver engaging and informative content. Contribute your own stories and photos to be part of the community!

Tag: Adaptive Biotechnologies Stock

Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?

Quick Links

Categories